{
    "0I1.F": {
        "short_name": "MYHEALTHCHECKED  LS -,001",
        "long_name": "MyHealthChecked Plc",
        "summary": "MyHealthChecked Plc, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers myLotus, a dual purpose monitoring system that allows both ovulation (LH) and pregnancy (hCG) testing. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is based in Cardiff, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Cardiff",
        "zipcode": "CF24 5EA",
        "website": "http://myhealthcheckedplc.com",
        "full_time_employees": 16
    },
    "1RC.SG": {
        "short_name": "Creo Medical Group PLC Register",
        "long_name": "Creo Medical Limited",
        "summary": "Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Speedboat RS2, a medical instrument through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Chepstow",
        "zipcode": "NP16 5UH",
        "website": "http://creomedical.com",
        "full_time_employees": 175
    },
    "4KM.SG": {
        "short_name": "Kromek Group PLC Registered Sha",
        "long_name": "Kromek Group plc",
        "summary": "Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for medical imaging, nuclear detection, and security screening markets in the United Kingdom, North America, Asia, Europe, and Australasia. Its solutions provide high-resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and EV-CPG compact gamma ray detectors, as well as quant GR1 shielded gamma detectors, multichannel analyzers, CZT-based gamma ray imagers, quant air, scalable x-ray CZR linear array, gamma-ray spectroscopy software, gamma ray radionuclide detectors, and voltage to frequency converters. In addition, it offers medical imaging products, including CZT gamma detector for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT. Further, the company provides security products, such as D3 PRD high accuracy, D3M, and D3S PRD personal radiation detectors; D3S wearable RIID gamma neutron detectors; D3S NET networked radiation detectors and static node; static radiation detector; vehicle mounted radiation detectors; UAV radiation mapping drone and AARM system; liquid explosive detection algorithm; and Identifier liquid explosive detectors. Additionally, it engages in scientific research and development activities. The company sells its products through distributors, OEM, and direct sales. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "STU",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Sedgefield",
        "zipcode": "TS21 3FD",
        "website": "http://www.kromek.com",
        "full_time_employees": 100
    },
    "AOHA.F": {
        "short_name": "RUA LIFE SCIENCES  LS0,05",
        "long_name": "Rua Life Sciences Plc",
        "summary": "Rua Life Sciences Plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to Rua Life Sciences Plc in June 2020. Rua Life Sciences Plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Irvine",
        "zipcode": "KA11 5AN",
        "website": "http://www.rualifesciences.com",
        "full_time_employees": 7
    },
    "AVO.L": {
        "short_name": "ADVANCED ONCOTHERAPY PLC ORD 25",
        "long_name": "Advanced Oncotherapy plc",
        "summary": "Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 1TE",
        "website": "http://www.avoplc.com",
        "full_time_employees": 129
    },
    "CREO.L": {
        "short_name": "CREO MEDICAL GROUP PLC ORD GBP0",
        "long_name": "Creo Medical Limited",
        "summary": "Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Speedboat RS2, a medical instrument through a combination of bipolar radiofrequency and microwave energy in a single platform for tissue dissection, resection, ablation, and coagulation. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was founded in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Chepstow",
        "zipcode": "NP16 5UH",
        "website": "http://creomedical.com",
        "full_time_employees": 175
    },
    "DEMG.L": {
        "short_name": "DELTEX MEDICAL GROUP PLC ORD 1P",
        "long_name": "Deltex Medical Group plc",
        "summary": "Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers Doppler Probes that is used to measure a patient's blood flow and fluid status directly from the descending aorta during surgery and critical care; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure wave algorithm for deriving haemodynamic parameters. The company's products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Chichester",
        "zipcode": "PO19 8TX",
        "website": "http://www.deltexmedical.com",
        "full_time_employees": null
    },
    "EVARF": {
        "short_name": "LOMBARD MED INC",
        "long_name": "Lombard Medical, Inc.",
        "summary": "Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Didcot",
        "zipcode": "OX11 7HJ",
        "website": "http://www.lombardmedical.com",
        "full_time_employees": 113
    },
    "IDH.L": {
        "short_name": "IMMUNODIAGNOSTIC SYSTEMS HOLDIN",
        "long_name": "Immunodiagnostic Systems Holdings PLC",
        "summary": "Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Boldon",
        "zipcode": "NE35 9PD",
        "website": "http://www.idsplc.com",
        "full_time_employees": 276
    },
    "IHC.L": {
        "short_name": "INSPIRATION HEALTHCARE GROUP PL",
        "long_name": "Inspiration Healthcare Group plc",
        "summary": "Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; AlphaCore5, a patient warming system for prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for management of body temperature in neonates. Inspiration Healthcare Group plc was founded in 1998 and is headquartered in Crawley, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Crawley",
        "zipcode": "RH10 9NE",
        "website": "http://www.inspiration-healthcare.com",
        "full_time_employees": null
    },
    "IUG.L": {
        "short_name": "INTELLIGENT ULTRASOUND GROUP PL",
        "long_name": "Intelligent Ultrasound Group plc",
        "summary": "Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators in the United Kingdom, North America, and internationally. It also develops clinical ultrasound software. The company's clinical AI software products include ScanNav Audit, an AI-based ultrasound software product that provides real-time support for ultrasound practitioners, which performs fetal anomaly scans; ScanNav AutoCapture, an AI-based ultrasound software product that automatically captures images; and ScanNav AnatomyGuide, an AI based ultrasound software product, which can automatically identify and highlight key anatomical structures in a live ultrasound image. Its simulator training platforms, comprises of ScanTrainer, a haptic-based ultrasound simulator for obstetrics and gynaecology training markets; HeartWorks, a manikin-based ultrasound simulator for cardiac and anaesthesiology training markets; and BodyWorks, a manikin-based ultrasound simulators for PoCUS, emergency medicine, critical care, and intensive care training markets. The company was formerly known as MedaPhor Group plc and changed its name to Intelligent Ultrasound Group plc in January 2019. Intelligent Ultrasound Group plc was founded in 2004 and is headquartered in Cardiff, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Cardiff",
        "zipcode": "CF10 1DY",
        "website": "http://www.intelligentultrasound.com",
        "full_time_employees": null
    },
    "KMK.L": {
        "short_name": "KROMEK GROUP PLC ORD 1P",
        "long_name": "Kromek Group plc",
        "summary": "Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection products for medical imaging, nuclear detection, and security screening markets in the United Kingdom, North America, Asia, Europe, and Australasia. Its solutions provide high-resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, as well as for the analysis of radioactive materials. The company also provides a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology, such as handheld rugged gamma detectors, thermal neutron detectors, gamma-ray detector spectrometers, scintillator detectors, preamplifiers for radiation detectors and detector electronics, and EV-CPG compact gamma ray detectors, as well as quant GR1 shielded gamma detectors, multichannel analyzers, CZT-based gamma ray imagers, quant air, scalable x-ray CZR linear array, gamma-ray spectroscopy software, gamma ray radionuclide detectors, and voltage to frequency converters. In addition, it offers medical imaging products, including CZT gamma detector for SPECT imaging, CZT bone mineral densitometry detectors, and photon-counting spectral CT. Further, the company provides security products, such as D3 PRD high accuracy, D3M, and D3S PRD personal radiation detectors; D3S wearable RIID gamma neutron detectors; D3S NET networked radiation detectors and static node; static radiation detector; vehicle mounted radiation detectors; UAV radiation mapping drone and AARM system; liquid explosive detection algorithm; and Identifier liquid explosive detectors. Additionally, it engages in scientific research and development activities. The company sells its products through distributors, OEM, and direct sales. Kromek Group plc was incorporated in 2013 and is headquartered in Sedgefield, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Sedgefield",
        "zipcode": "TS21 3FD",
        "website": "http://www.kromek.com",
        "full_time_employees": 100
    },
    "LIA.F": {
        "short_name": "LIVANOVA PLC  DL -,01",
        "long_name": "LivaNova PLC",
        "summary": "LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W2 6LG",
        "website": "http://www.livanova.com",
        "full_time_employees": 4000
    },
    "LIVN": {
        "short_name": "LivaNova PLC",
        "long_name": "LivaNova PLC",
        "summary": "LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NMS",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W2 6LG",
        "website": "http://www.livanova.com",
        "full_time_employees": 4000
    },
    "LWX.F": {
        "short_name": "IMMUNODIAGNOSTIC  LS -,02",
        "long_name": "Immunodiagnostic Systems Holdings PLC",
        "summary": "Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Boldon",
        "zipcode": "NE35 9PD",
        "website": "http://www.idsplc.com",
        "full_time_employees": 276
    },
    "LXD1.F": {
        "short_name": "INSPIRATION HEA.GR.LS-,10",
        "long_name": "Inspiration Healthcare Group plc",
        "summary": "Inspiration Healthcare Group plc, together with its subsidiaries, provides medical devices for use in critical care, operating theatre, and home healthcare applications worldwide. The company offers neonatal intensive care products, such as Unique+ CFM, a wireless electroencephalography monitoring device; a nasal continuous positive airway pressure (nCPAP) device for treating infants, as well as a range of breathing circuits under the Inspire nCPAP name; inspiration air/oxygen blenders; and Tecotherm Neo, a servo control device for total body cooling and warming used in initial stabilization of preterm infants. Its neonatal intensive care products also include LifeStart, a neonatal bedside resuscitation unit; and Inspire rPAP, a 2-piece non-invasive system for the initial stabilization and resuscitation of infants. In addition, the company provides adult intensive care products; AlphaCore5, a patient warming system for prevention of inadvertent hypothermia; and CosyTherm2, a patient warming system for management of body temperature in neonates. Inspiration Healthcare Group plc was founded in 1998 and is headquartered in Crawley, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Crawley",
        "zipcode": "RH10 9NE",
        "website": "http://www.inspiration-healthcare.com",
        "full_time_employees": null
    },
    "MGP.L": {
        "short_name": "MEDICA GROUP PLC ORD 0.2P",
        "long_name": "Medica Group Plc",
        "summary": "Medica Group Plc provides teleradiology reporting services to NHS trusts, private hospital groups, and diagnostic imaging companies in the United Kingdom. It offers NightHawk emergency computerised tomography (CT) and MR reporting, routine cross sectional, routine plain film, and radiographer plain film services. The company also provides audit services, such as cause for concern audit, departmental quality assurance, and ongoing CT, MR, plain film, and ultrasound audit services; and multiparametric prostate magnetic resonance imaging, specialist cardiac reporting, CT colonoscopy, DXA reporting, nuclear medicine examination, tailored cancer reporting, PET-CT, and CBCT services. Medica Group Plc was incorporated in 2013 and is based in Hastings, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Hastings",
        "zipcode": "TN34 1EA",
        "website": "http://www.medicagroup.co.uk",
        "full_time_employees": 120
    },
    "MHC.L": {
        "short_name": "MYHEALTHCHECKED PLC ORD 0.1P",
        "long_name": "MyHealthChecked Plc",
        "summary": "MyHealthChecked Plc, a women's healthcare company, develops and commercializes mobile health diagnostics medical devices in the United Kingdom. Its products help women with unexplained infertility to concieve. The company offers myLotus, a dual purpose monitoring system that allows both ovulation (LH) and pregnancy (hCG) testing. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is based in Cardiff, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Cardiff",
        "zipcode": "CF24 5EA",
        "website": "http://myhealthcheckedplc.com",
        "full_time_employees": 16
    },
    "NPW1.F": {
        "short_name": "SMITH + NEP.  DL -,20",
        "long_name": "Smith & Nephew plc",
        "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Watford",
        "zipcode": "WD18 8YE",
        "website": "http://www.smith-nephew.com",
        "full_time_employees": 17914
    },
    "NPWA.F": {
        "short_name": "SMITH+NEPHEW ADR5 DL-20/2",
        "long_name": "Smith & Nephew plc",
        "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Watford",
        "zipcode": "WD18 8YE",
        "website": "http://www.smith-nephew.com",
        "full_time_employees": 17914
    },
    "R3I1.F": {
        "short_name": "ADVANCED ONCOTHER. LS-,25",
        "long_name": "Advanced Oncotherapy plc",
        "summary": "Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, selling, and maintaining proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "FRA",
        "market": "dr_market",
        "country": "United Kingdom",
        "state": null,
        "city": "London",
        "zipcode": "W1S 1TE",
        "website": "http://www.avoplc.com",
        "full_time_employees": 129
    },
    "RUA.L": {
        "short_name": "RUA LIFE SCIENCES PLC ORD 5P",
        "long_name": "Rua Life Sciences Plc",
        "summary": "Rua Life Sciences Plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to Rua Life Sciences Plc in June 2020. Rua Life Sciences Plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Irvine",
        "zipcode": "KA11 5AN",
        "website": "http://www.rualifesciences.com",
        "full_time_employees": 7
    },
    "SN.L": {
        "short_name": "SMITH & NEPHEW PLC ORD USD0.20",
        "long_name": "Smith & Nephew plc",
        "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Watford",
        "zipcode": "WD18 8YE",
        "website": "http://www.smith-nephew.com",
        "full_time_employees": 17914
    },
    "SNN": {
        "short_name": "Smith & Nephew SNATS, Inc.",
        "long_name": "Smith & Nephew plc",
        "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "NYQ",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Watford",
        "zipcode": "WD18 8YE",
        "website": "http://www.smith-nephew.com",
        "full_time_employees": 17914
    },
    "SNNUF": {
        "short_name": "SMITH & NEPHEW",
        "long_name": "Smith & Nephew plc",
        "summary": "Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Watford",
        "zipcode": "WD18 8YE",
        "website": "http://www.smith-nephew.com",
        "full_time_employees": 17914
    },
    "SUN.L": {
        "short_name": "SURGICAL INNOVATIONS GROUP PLC ",
        "long_name": "Surgical Innovations Group plc",
        "summary": "Surgical Innovations Group plc designs, develops, manufactures, and sells devices for use in minimally invasive surgery (SI) and precision engineering markets in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company's SI Brand segment researches, develops, manufactures, and distributes SI branded minimally invasive devices. This segment also offers YelloPort Elite and YelloPort +plus laparoscopic port access systems; LogiRange resposable laparoscopic instrument systems; FastClamp laparoscopic clamping systems; and QuickRange single use laparoscopic instrumentation. Its OEM segment researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through own label or co-branding. This segment also provides design and development solutions for producing a final device; and researches, develops, manufactures, and sells minimally invasive technology products for precision engineering applications. The company's Distribution segment distributes medical products through Elemental Healthcare Ltd. It also designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. Surgical Innovations Group plc was incorporated in 1988 and is based in Leeds, the United Kingdom.",
        "currency": "GBp",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "LSE",
        "market": "gb_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Leeds",
        "zipcode": "LS16 6QZ",
        "website": "http://www.sigroupplc.com",
        "full_time_employees": 83
    },
    "VICA": {
        "short_name": "RAFINA INNOVATIONS INC",
        "long_name": "Rafina Innovations Inc.",
        "summary": "Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Medical Devices",
        "exchange": "PNK",
        "market": "us_market",
        "country": "United Kingdom",
        "state": null,
        "city": "Glasgow",
        "zipcode": "G51 1HJ",
        "website": "http://rafina-innovations.com",
        "full_time_employees": 4
    }
}